anti-TNFSF9 antibody product blog
Tags: Antibody; Monoclonal Antibody; anti-TNFSF9 antibody; TNFSF9;
The CD137L tnfsf9 (Catalog #MBS2549157) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CD137L Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD137L can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), ELISA (EIA).WB: 1:1000-1:4000. Researchers should empirically determine the suitability of the CD137L tnfsf9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD137L tnfsf9 product has the following accession number(s) (GI #4507609) (NCBI Accession #NP_003802.1) (Uniprot Accession #P41273). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CD137L Monoclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of Raji, Ramos, Daudi, and K-562 cells using TNFSF9 Monoclonal Antibody at dilution of 1:2000.)
TNFSF9, also named as 4-1BBL, belongs to the tumor necrosis factor family. It is a cytokine that binds to TNFRSF9. TNSF9 induces the proliferation of activated peripheral blood T-cells. It may have a role in activation-induced cell death (AICD) and may play a role in cognate interactions between T-cells and B-cells/macrophages.
Immunogen: Fusion protein of TNFSF9. Buffer: PBS with 0.02% sodium azide, 50% glycerol, PH7.3
Conjugation: Unconjugated. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD137L are readily searchable from our website. Different antibodies against the same target such as CD137L may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Carcinoma, Hepatocellular, Cardiovascular Diseases, Gastrointestinal Diseases, Inflammation, Liver Diseases, Liver Neoplasms, Lymphoma, Necrosis, Neoplasms, Neoplasms, Experimental are some of the diseases may be linked to CD137L Monoclonal Antibody. CD137L also interacts with the following gene(s): TNFRSF9, TRAF1, TRAF2. Blood, Bone, Brain, Cervix, Eye, Intestine, Nerve, Prostate, Stomach tissues are correlated with this protein.